Nufabrx

Nufabrx, based in North Carolina, specializes in textile-based medical solutions that incorporate pain-relieving medications into apparel, providing innovative relief for musculoskeletal conditions. Nufabrx offers advanced apparel products designed to alleviate pain using therapeutic medications embedded within the fabrics. Founded in 2012, the company is headquartered in North Carolina, US. In February 2026, Nufabrx raised USD 5 million in venture funding from new investor Meltzer Capital.

Jordan Schindler is the founder, while Glenn Normoyle serves as the CEO. Nufabrx provides innovative apparel products that combine pain-relieving medicine with compression technology, primarily targeting individuals suffering from various musculoskeletal conditions. Their core product line includes compression sleeves and wraps for the ankle, arm, back, calf, elbow, knee, leg, neck, and wrist. These products utilize a patented process that infuses therapeutic medication directly into the fabric, allowing for controlled release upon skin contact, effectively addressing pain management.

The intended end-user demographic primarily consists of athletes, military veterans, and individuals with chronic pain conditions, such as arthritis. Nufabrx's products are marketed through direct-to-consumer channels and are also available in select retail environments across the United States and internationally, emphasizing accessibility for those in need of pain relief solutions. Nufabrx generates revenue through a combination of direct-to-consumer sales and retail partnerships, providing consumers with a seamless purchasing experience for their pain-relieving products. Customers can purchase individual items, such as their flagship compression sleeves, directly from their website or through participating retailers.

This model supports a straightforward pricing structure, allowing consumers to acquire the necessary products for their specific health needs without ongoing commitments. Revenue streams are bolstered by the company’s focus on high-quality, laundry-safe products that provide a consistent and effective dosage of pain relief, ensuring customer satisfaction and repeat purchases. The integration of special offers and promotions further enhances customer engagement and sales volume. The company plans to utilize the February 2026 funding to drive ongoing growth by advancing product development, expanding its distribution network, and boosting brand visibility.